Table of Contents

Executive Summary

1 Industry Overview of Pneumonia Therapeutics

• 1.1 Definition of Pneumonia Therapeutics
• 1.2 Pneumonia Therapeutics Segment by Type
  • 1.2.1 Global Pneumonia Therapeutics Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Vaccines
  • 1.2.3 Anti-Infectives
  • 1.2.4 Oxygen Therapy
• 1.3 Pneumonia Therapeutics Segment by Applications
  • 1.3.1 Global Pneumonia Therapeutics Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Medical Center
  • 1.3.5 Other
• 1.4 Global Pneumonia Therapeutics Overall Market
  • 1.4.1 Global Pneumonia Therapeutics Revenue (2014-2025)
  • 1.4.2 Global Pneumonia Therapeutics Production (2014-2025)
  • 1.4.3 North America Pneumonia Therapeutics Status and Prospect (2014-2025)
  • 1.4.4 Europe Pneumonia Therapeutics Status and Prospect (2014-2025)
  • 1.4.5 China Pneumonia Therapeutics Status and Prospect (2014-2025)
  • 1.4.6 Japan Pneumonia Therapeutics Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Pneumonia Therapeutics Status and Prospect (2014-2025)
  • 1.4.8 India Pneumonia Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Pneumonia Therapeutics
• 2.3 Manufacturing Process Analysis of Pneumonia Therapeutics
• 2.4 Industry Chain Structure of Pneumonia Therapeutics

3 Development and Manufacturing Plants Analysis of Pneumonia Therapeutics

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Pneumonia Therapeutics Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Pneumonia Therapeutics
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Pneumonia Therapeutics Production and Capacity Analysis
• 4.2 Pneumonia Therapeutics Revenue Analysis
• 4.3 Pneumonia Therapeutics Price Analysis
• 4.4 Market Concentration Degree

5 Pneumonia Therapeutics Regional Market Analysis

• 5.1 Pneumonia Therapeutics Production by Regions
  • 5.1.1 Global Pneumonia Therapeutics Production by Regions
  • 5.1.2 Global Pneumonia Therapeutics Revenue by Regions
• 5.2 Pneumonia Therapeutics Consumption by Regions
• 5.3 North America Pneumonia Therapeutics Market Analysis
  • 5.3.1 North America Pneumonia Therapeutics Production
  • 5.3.2 North America Pneumonia Therapeutics Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Pneumonia Therapeutics Import and Export
• 5.4 Europe Pneumonia Therapeutics Market Analysis
  • 5.4.1 Europe Pneumonia Therapeutics Production
  • 5.4.2 Europe Pneumonia Therapeutics Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Pneumonia Therapeutics Import and Export
• 5.5 China Pneumonia Therapeutics Market Analysis
  • 5.5.1 China Pneumonia Therapeutics Production
  • 5.5.2 China Pneumonia Therapeutics Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Pneumonia Therapeutics Import and Export
• 5.6 Japan Pneumonia Therapeutics Market Analysis
  • 5.6.1 Japan Pneumonia Therapeutics Production
  • 5.6.2 Japan Pneumonia Therapeutics Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Pneumonia Therapeutics Import and Export
• 5.7 Southeast Asia Pneumonia Therapeutics Market Analysis
  • 5.7.1 Southeast Asia Pneumonia Therapeutics Production
  • 5.7.2 Southeast Asia Pneumonia Therapeutics Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Pneumonia Therapeutics Import and Export
• 5.8 India Pneumonia Therapeutics Market Analysis
  • 5.8.1 India Pneumonia Therapeutics Production
  • 5.8.2 India Pneumonia Therapeutics Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Pneumonia Therapeutics Import and Export

6 Pneumonia Therapeutics Segment Market Analysis (by Type)

• 6.1 Global Pneumonia Therapeutics Production by Type
• 6.2 Global Pneumonia Therapeutics Revenue by Type
• 6.3 Pneumonia Therapeutics Price by Type

7 Pneumonia Therapeutics Segment Market Analysis (by Application)

• 7.1 Global Pneumonia Therapeutics Consumption by Application
• 7.2 Global Pneumonia Therapeutics Consumption Market Share by Application (2014-2019)

8 Pneumonia Therapeutics Major Manufacturers Analysis

• 8.1 GlaxoSmithKline
  • 8.1.1 GlaxoSmithKline Pneumonia Therapeutics Production Sites and Area Served
  • 8.1.2 GlaxoSmithKline Product Introduction, Application and Specification
  • 8.1.3 GlaxoSmithKline Pneumonia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Merck Sharp & Dohme
  • 8.2.1 Merck Sharp & Dohme Pneumonia Therapeutics Production Sites and Area Served
  • 8.2.2 Merck Sharp & Dohme Product Introduction, Application and Specification
  • 8.2.3 Merck Sharp & Dohme Pneumonia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Novartis
  • 8.3.1 Novartis Pneumonia Therapeutics Production Sites and Area Served
  • 8.3.2 Novartis Product Introduction, Application and Specification
  • 8.3.3 Novartis Pneumonia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Pfizer
  • 8.4.1 Pfizer Pneumonia Therapeutics Production Sites and Area Served
  • 8.4.2 Pfizer Product Introduction, Application and Specification
  • 8.4.3 Pfizer Pneumonia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 AstraZeneca
  • 8.5.1 AstraZeneca Pneumonia Therapeutics Production Sites and Area Served
  • 8.5.2 AstraZeneca Product Introduction, Application and Specification
  • 8.5.3 AstraZeneca Pneumonia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Bayer
  • 8.6.1 Bayer Pneumonia Therapeutics Production Sites and Area Served
  • 8.6.2 Bayer Product Introduction, Application and Specification
  • 8.6.3 Bayer Pneumonia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Biotest
  • 8.7.1 Biotest Pneumonia Therapeutics Production Sites and Area Served
  • 8.7.2 Biotest Product Introduction, Application and Specification
  • 8.7.3 Biotest Pneumonia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Tetraphase Pharmaceuticals
  • 8.8.1 Tetraphase Pharmaceuticals Pneumonia Therapeutics Production Sites and Area Served
  • 8.8.2 Tetraphase Pharmaceuticals Product Introduction, Application and Specification
  • 8.8.3 Tetraphase Pharmaceuticals Pneumonia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Pneumonia Therapeutics Market

• 9.1 Global Pneumonia Therapeutics Market Trend Analysis
  • 9.1.1 Global Pneumonia Therapeutics Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Pneumonia Therapeutics Regional Market Trend
  • 9.2.1 North America Pneumonia Therapeutics Forecast 2019-2025
  • 9.2.2 Europe Pneumonia Therapeutics Forecast 2019-2025
  • 9.2.3 China Pneumonia Therapeutics Forecast 2019-2025
  • 9.2.4 Japan Pneumonia Therapeutics Forecast 2019-2025
  • 9.2.5 Southeast Asia Pneumonia Therapeutics Forecast 2019-2025
  • 9.2.6 India Pneumonia Therapeutics Forecast 2019-2025
• 9.3 Pneumonia Therapeutics Market Trend (Product Type)
• 9.4 Pneumonia Therapeutics Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Pneumonia Therapeutics Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection.
The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years.

The global Pneumonia Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pneumonia Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pneumonia Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pneumonia Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pneumonia Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
GlaxoSmithKline
Merck Sharp & Dohme
Novartis
Pfizer
AstraZeneca
Bayer
Biotest
Tetraphase Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Vaccines
Anti-Infectives
Oxygen Therapy

Segment by Application
Hospital
Clinic
Medical Center
Other